Evogene (EVGN) Assets Average (2017 - 2025)
Evogene (EVGN) has disclosed Assets Average for 5 consecutive years, with $195.3 million as the latest value for Q4 2025.
- Quarterly Assets Average fell 18.44% to $195.3 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $195.3 million through Dec 2025, down 18.44% year-over-year, with the annual reading at $30.0 million for FY2025, 34.14% down from the prior year.
- Assets Average hit $195.3 million in Q4 2025 for Evogene, down from $239.4 million in the prior quarter.
- In the past five years, Assets Average ranged from a high of $239.4 million in Q4 2024 to a low of $195.3 million in Q4 2025.
- Historically, Assets Average has averaged $221.5 million across 3 years, with a median of $229.9 million in 2023.
- Biggest five-year swings in Assets Average: grew 4.14% in 2024 and later decreased 18.44% in 2025.
- Year by year, Assets Average stood at $229.9 million in 2023, then grew by 4.14% to $239.4 million in 2024, then fell by 18.44% to $195.3 million in 2025.
- Business Quant data shows Assets Average for EVGN at $195.3 million in Q4 2025, $239.4 million in Q4 2024, and $229.9 million in Q4 2023.